For the roughly 6 million Americans living with atrial fibrillation, catheter ablation has become an increasingly common ...

Corify Care today announced that the U.S. Food and Drug Administration (FDA) has granted clearance for the ACORYS® System, ...

Corify Care announced today that it received FDA clearance for its Acorys imageless, non-invasive cardiac mapping platform.

The complete study cohort includes 1,023 patients from 22 sites in Europe.

Johnson & Johnson today announced positive 12-month interim effectiveness and safety results from a study of its Varipulse ...

The Varipulse Pro pulsed field ablation platform, which has received a CE mark, will be a focus at the upcoming European ...

From its first use in 1998, to its status as a routine management strategy when medication is not an option, our understanding of catheter ablation for AF has grown immensely 4. Over the past 28 years ...

U.S. IDE Enrollment follows groundbreaking 96% procedural success at 12 months in European feasibility studyHAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of ...

NEW YORK--(BUSINESS WIRE)--ACCESS GPO today announced a preferred, multi-year agreement with Medtronic to support availability of the Affera™ Mapping and Ablation System with Sphere-9™ Catheter in ...